Feeds
3807 items (3807 unread) in 74 feeds
Acinar Cell Carcinoma
(40 unread)
Acinic Cell Carcinoma
(50 unread)
Adenoid Cystic Carcinoma
(96 unread)
Adrenal Gland Cancer
(350 unread)
Ampulla Of Vater
(53 unread)
Anal Cancer
(367 unread)
Angiosarcoma
(88 unread)
Appendix Cancer
(50 unread)
Bile Duct Cancer
(400 unread)
Brain and CNS
(353 unread)
Carcinoid
(144 unread)
Endocrine/Neuroendocrine
(453 unread)
Gall Bladder Cancer
(301 unread)
Hemangioendothelioma
(90 unread)
Hepatoblastoma
(50 unread)
Pancreas
(28 unread)
Phyllodes
(17 unread)
PMP and Mucinous Tumors
(22 unread)
Rhabdomyosarcoma
(212 unread)
Sarcoma
(643 unread)
Google - Rare CNS Tumor (87 unread)
-
New AI for mammography scans aims to aid rather than replace human decision-making — ScienceDaily - newsconcerns
Posted: January 15th, 2022, 1:20am GMT
-
Tingling in the Head: Causes and Treatments - Verywell Health
Posted: January 14th, 2022, 8:14pm GMT
Tingling in the Head: Causes and Treatments Verywell Health -
Optimized Treatment Starts With Molecular Testing in NSCLC - OncLive
Posted: January 14th, 2022, 2:41pm GMT
-
Burden of brain cancer will continue to rise in the US ageing population - Clinical Trials Arena
Posted: January 14th, 2022, 2:30pm GMT
Burden of brain cancer will continue to rise in the US ageing population Clinical Trials Arena -
Pharma Stock Roundup: PFE's Research Deal With BEAM & Other Updates - Nasdaq
Posted: January 14th, 2022, 1:07pm GMT
-
In Vivo's Deals Of The Year 2021: Cast Your Vote! - In Vivo
Posted: January 13th, 2022, 8:27am GMT
-
Innovation and access: Improving Europe's pharmaceutical regulatory framework - - pharmaphorum
Posted: January 13th, 2022, 8:22am GMT
-
Socinski Evaluates Rationale for Treatment Options in Patients With Rare Driver Mutations in Lung Cancer - Targeted Oncology
Posted: January 12th, 2022, 2:00pm GMT
-
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer - AJMC.com Managed Markets Network
Posted: January 11th, 2022, 2:09pm GMT
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer AJMC.com Managed Markets Network -
Diagnosis and Management of TRK Fusion Cancer - AJMC.com Managed Markets Network
Posted: January 11th, 2022, 2:09pm GMT
Diagnosis and Management of TRK Fusion Cancer AJMC.com Managed Markets Network -
New year, new cell and gene therapy collaborations - European Pharmaceutical Review
Posted: January 11th, 2022, 10:23am GMT
New year, new cell and gene therapy collaborations European Pharmaceutical Review -
In historic first, surgeons transplant a genetically modified pig heart into a dying patient - Endpoints News
Posted: January 11th, 2022, 10:17am GMT
-
Biopharma Executive Perspectives on 2022 - BioSpace
Posted: January 10th, 2022, 12:17pm GMT
-
BioNTech, Crescendo Biologics Ink 3-year Deal For Multi-target Discovery - Quick Facts - Nasdaq
Posted: January 10th, 2022, 12:12pm GMT
-
Buy This Value Stock Before Everyone Else Does - Nasdaq
Posted: January 10th, 2022, 12:04pm GMT
-
U.S. Stocks May See Further Downside In Early Trading - Nasdaq
Posted: January 10th, 2022, 11:58am GMT
-
Biomea Fusion Announces 2022 Clinical Development Plan to Initiate Studies in up to Seven ... - The Bakersfield Californian
Posted: January 10th, 2022, 11:30am GMT
Biomea Fusion Announces 2022 Clinical Development Plan to Initiate Studies in up to Seven ... The Bakersfield Californian -
Biomea Fusion Announces 2022 Clinical Development Plan to - GlobeNewswire
Posted: January 10th, 2022, 11:30am GMT
-
Denali Therapeutics Announces Progression and Expansion of - GlobeNewswire
Posted: January 10th, 2022, 11:00am GMT
-
Maze Therapeutics refuels with another $190M to prove its genetic modifiers approach holds up in the clinic - Endpoints News
Posted: January 10th, 2022, 10:30am GMT
-
JP Morgan 2022 – day one sees healthy deal flow from biopharma - Vantage
Posted: January 10th, 2022, 10:00am GMT
-
In $900M+ deal, rare disease biotechs team up on RNA therapies for CNS developmental disorders - Endpoints News
Posted: January 10th, 2022, 10:00am GMT
-
Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases - InvestingNews.com
Posted: January 10th, 2022, 9:46am GMT
-
Why Does My Tongue Feel Weird? - Talk Radio News Service
Posted: January 7th, 2022, 3:19pm GMT
Why Does My Tongue Feel Weird? Talk Radio News Service -
Planting another flag on Pfizer and Alnylam's turf, AstraZeneca grabs amyloidosis drug from the biotech that invented Aduhelm - Endpoints News
Posted: January 7th, 2022, 10:06am GMT
-
Endoscopic treatment of solitary gastric neurofibroma | IJGM - Dove Medical Press
Posted: January 6th, 2022, 5:50am GMT
Endoscopic treatment of solitary gastric neurofibroma | IJGM Dove Medical Press -
Confused about Confusion | NEJM - nejm.org
Posted: January 5th, 2022, 8:01pm GMT
Confused about Confusion | NEJM nejm.org -
Brain tumours: Treatment challenges and how to support patients who receive a diagnosis - Nursing Standard
Posted: January 5th, 2022, 7:21am GMT
-
10 Biggest Novel Drug Approvals of 2021 – PharmaLive - PharmaLive
Posted: January 4th, 2022, 4:26pm GMT
-
5 Sizzling ‘Strong Buy’ Analyst Biotechnology Picks for 2022 - 24/7 Wall St.
Posted: January 4th, 2022, 10:15am GMT
-
Advancing precision medicine through agile governance - Brookings Institution
Posted: January 4th, 2022, 3:18am GMT
Advancing precision medicine through agile governance Brookings Institution -
Key immune-related genes in COPD | COPD - Dove Medical Press
Posted: January 3rd, 2022, 10:05am GMT
Key immune-related genes in COPD | COPD Dove Medical Press -
Legacy of young cancer victim continues | News, Sports, Jobs - SalemNews.net
Posted: January 3rd, 2022, 3:14am GMT
-
Immunotherapy for Neuro-oncology - DocWire News
Posted: January 1st, 2022, 4:00am GMT
Immunotherapy for Neuro-oncology DocWire News -
Immunotherapy for Neuro-oncology - DocWire News
Posted: January 1st, 2022, 4:00am GMT
Immunotherapy for Neuro-oncology DocWire News -
5 Beaten-Down Biotech Bets to Bounce Back in 2022 - Nasdaq
Posted: December 31st, 2021, 4:50pm GMT
-
Primary testicular lymphoma patients with CNS relapse | CMAR - Dove Medical Press
Posted: December 31st, 2021, 7:58am GMT
Primary testicular lymphoma patients with CNS relapse | CMAR Dove Medical Press -
Welireg May Promote Strong Clinical Activity in VHL-Associated Kidney Cancer With Mild Side Effects - Curetoday.com
Posted: December 30th, 2021, 8:05pm GMT
-
Philadelphia-area life sciences companies top $1 billion in VC investments in 2021 - Philadelphia Business Journal - Philadelphia Business Journal
Posted: December 30th, 2021, 6:58pm GMT
Philadelphia-area life sciences companies top $1 billion in VC investments in 2021 - Philadelphia Business Journal Philadelphia Business Journal -
The 10 Biggest Drug Approvals of 2021 - BioSpace
Posted: December 30th, 2021, 6:21pm GMT
-
Unwelcome changes - Meduza
Posted: December 30th, 2021, 2:41pm GMT
Unwelcome changes Meduza -
10 Biggest Novel Drug Approvals of 2021 – PharmaLive - PharmaLive
Posted: December 30th, 2021, 2:39pm GMT
-
4 Biotechs That Could Be Potential Takeover Targets in 2022 - Nasdaq
Posted: December 30th, 2021, 9:52am GMT
-
Assessing medical students' knowledge of genetics | AMEP - Dove Medical Press
Posted: December 30th, 2021, 10:06pm GMT
Assessing medical students' knowledge of genetics | AMEP Dove Medical Press -
Top 5 Brain Cancer News Stories of 2021 - Curetoday.com
Posted: December 29th, 2021, 6:01pm GMT
Top 5 Brain Cancer News Stories of 2021 Curetoday.com -
CBD Oil — Are the Benefits Claimed Too Good To Be True? - Health Essentials from Cleveland Clinic
Posted: December 29th, 2021, 9:30am GMT
CBD Oil — Are the Benefits Claimed Too Good To Be True? Health Essentials from Cleveland Clinic -
Systematic pan-cancer analysis of KIF23 | PGPM - Dove Medical Press
Posted: December 29th, 2021, 9:20am GMT
Systematic pan-cancer analysis of KIF23 | PGPM Dove Medical Press -
Renal cell carcinoma during pregnancy | CMAR - Dove Medical Press
Posted: December 29th, 2021, 4:46am GMT
Renal cell carcinoma during pregnancy | CMAR Dove Medical Press -
Legacy of young cancer victim continues | News, Sports, Jobs - The Review
Posted: December 29th, 2021, 3:47am GMT
-
Legacy of young cancer victim continues | News, Sports, Jobs - Morning Journal News
Posted: December 29th, 2021, 3:30am GMT
Legacy of young cancer victim continues | News, Sports, Jobs Morning Journal News -
2021's Top Biopharma Mergers and Acquisitions – PharmaLive - PharmaLive
Posted: December 29th, 2021, 2:51am GMT
-
Akron mom fights for brain-cancer research - LimaOhio.com
Posted: December 24th, 2021, 3:15pm GMT
Akron mom fights for brain-cancer research LimaOhio.com -
Through chance meeting, a driving spirit and – of all things, beer - an Akron mom fights for brain-cancer res - cleveland.com
Posted: December 24th, 2021, 6:00am GMT
-
NEUBASE THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - marketscreener.com
Posted: December 23rd, 2021, 7:09pm GMT
-
Self-limited Primary Cutaneous Rosai-Dorfman disease | CCID - Dove Medical Press
Posted: December 23rd, 2021, 2:25pm GMT
Self-limited Primary Cutaneous Rosai-Dorfman disease | CCID Dove Medical Press -
Case 39-2021: A 26-Year-Old Woman with Respiratory Failure and Altered Mental Status | NEJM - nejm.org
Posted: December 22nd, 2021, 8:02pm GMT
-
The complexity of carcinosarcoma - Cancer Network
Posted: December 21st, 2021, 1:10pm GMT
The complexity of carcinosarcoma Cancer Network -
FDA grants orphan drug designation to silmitasertib for medulloblastoma - Healio
Posted: December 21st, 2021, 12:40pm GMT
-
Influence of GSTP-1 polymorphism on the prognosis of glioma | IJGM - Dove Medical Press
Posted: December 21st, 2021, 11:42am GMT
Influence of GSTP-1 polymorphism on the prognosis of glioma | IJGM Dove Medical Press -
In This Issue - pnas.org
Posted: December 21st, 2021, 6:00am GMT
In This Issue pnas.org -
Specialty Drug Approvals: A Year of Firsts - Pharmacy Practice News
Posted: December 21st, 2021, 3:06am GMT
Specialty Drug Approvals: A Year of Firsts Pharmacy Practice News -
Merck KGaA snatches up Geneva biotech as repurposed chemotherapy mission strikes a 'Chord' - Endpoints News
Posted: December 20th, 2021, 1:56pm GMT
-
Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus‐2 - Wiley
Posted: December 20th, 2021, 6:00am GMT
-
All About Frontal Lobe Epilepsy (FLE) - Healthline
Posted: December 17th, 2021, 7:29pm GMT
All About Frontal Lobe Epilepsy (FLE) Healthline -
How Oligodendroglioma Is Treated - Brain Tumors - Verywell Health
Posted: December 17th, 2021, 7:26pm GMT
How Oligodendroglioma Is Treated - Brain Tumors Verywell Health -
These Healthcare Stocks Lagged This Year, But Might Offer Deep Value - Forbes
Posted: December 17th, 2021, 11:00am GMT
-
Covid-19 roundup: CDC recommends mRNA vaccines over J&J's due to rare blood clots; EU considers deal for variant-specific doses of Pfizer/BioNTech vaccine - Endpoints News
Posted: December 17th, 2021, 6:00am GMT
-
Systems biology analysis of human genomes points to key pathways conferring spina bifida risk - pnas.org
Posted: December 16th, 2021, 5:59pm GMT
-
These Healthcare Stocks Lagged This Year, But Might Offer Deep Value - Trefis
Posted: December 16th, 2021, 12:37pm GMT
-
Lockdown singing family on fast fame and charity single: 'We felt a bit ridiculous' - Yahoo Entertainment
Posted: December 16th, 2021, 9:10am GMT
-
Circulating Tumor DNA Could Be Used to Diagnose, Guide Treatment of CNS Lymphoma - Cancer Therapy Advisor
Posted: December 13th, 2021, 6:00am GMT
Circulating Tumor DNA Could Be Used to Diagnose, Guide Treatment of CNS Lymphoma Cancer Therapy Advisor -
Nick Cannon Reveals Infant Son Died After Developing Hydrocephalus From Brain Tumor | Health.com - Health.com
Posted: December 7th, 2021, 6:00am GMT
-
Bethel Park teen, a 2-time cancer survivor, committed to keeping his friend's memory alive - TribLIVE
Posted: December 1st, 2021, 6:00am GMT
-
How Pilocytic Astrocytoma Is Diagnosed - Cancer - Verywell Health
Posted: October 20th, 2021, 5:00am GMT
How Pilocytic Astrocytoma Is Diagnosed - Cancer Verywell Health -
CNN’s Andrew Kaczynski ran 26.2 in Boston to honor his infant daughter who died of brain cancer - The Boston Globe
Posted: October 11th, 2021, 5:00am GMT
-
Ain't no mountain high enough for fundraiser diagnosed with brain tumour - The Brain Tumour Charity
Posted: October 5th, 2021, 5:00am GMT
Ain't no mountain high enough for fundraiser diagnosed with brain tumour The Brain Tumour Charity -
Academia and industry efforts offer renewed hope for rare pediatric brain tumor therapy - The Pharma Letter
Posted: October 4th, 2021, 5:00am GMT
-
ESMO Publishes Guidelines for the Management of Solid Tumor Brain Metastases - OncLive
Posted: September 7th, 2021, 5:00am GMT
-
Liquid biopsies may aid diagnosis, treatment of bladder, nerve tumors: Blood, urine biopsies could pave way for more personalized cancer therapy - Science Daily
Posted: September 1st, 2021, 5:00am GMT
-
Primary Central Nervous System Vasculitis: From Diagnosis to Management - Neurology Advisor
Posted: September 1st, 2021, 5:00am GMT
Primary Central Nervous System Vasculitis: From Diagnosis to Management Neurology Advisor -
Future of Care for PCNSL Relies on Adapting Personalized Approaches - OncLive
Posted: August 23rd, 2021, 5:00am GMT
-
Melanoma Brain Metastases: 'Absolutely Treatable in 2021' - Cancer Therapy Advisor
Posted: July 5th, 2021, 5:00am GMT
Melanoma Brain Metastases: 'Absolutely Treatable in 2021' Cancer Therapy Advisor -
A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers - The Oncologist
Posted: April 23rd, 2021, 5:00am GMT
-
'She is My Inspiration': Glioblastoma Patient Watches His Daughter Grow Up | Dana-Farber - Dana-Farber Cancer Institute
Posted: April 14th, 2021, 5:00am GMT
'She is My Inspiration': Glioblastoma Patient Watches His Daughter Grow Up | Dana-Farber Dana-Farber Cancer Institute -
Perlmutter Cancer Center Researcher Advances Therapies for Difficult-to-Treat Brain Tumors - NYU Langone Health
Posted: December 1st, 2020, 6:00am GMT
-
Tumor Markers 'Valuable' for Relapse Detection in Rare CNS Tumors - medscape.com
Posted: June 29th, 2020, 5:00am GMT
-
First drug target identified for children with rare type of brain tumor - Science Daily
Posted: July 13th, 2016, 5:00am GMT